TRIAMCINOLONE ACETONIDE
| Brand name | XIPERE |
|---|---|
| Active ingredient | TRIAMCINOLONE ACETONIDE |
| Strength | 40MG/ML |
| Dosage form | SUSPENSION |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | October 2021 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12419833 | April 2040 | product |
| 9937075 | May 2034 | product |
| 9636332 | November 2033 | use U-3234 |
| 8636713 | May 2027 | use U-3234 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.